Aspiriant LLC’s iMGP DBi Managed Futures Strategy ETF DBMF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.78M Sell
123,644
-2,874
-2% -$88.3K 0.09% 84
2026
Q1
$3.81M Sell
126,518
-4,086
-3% -$122K 0.11% 81
2025
Q4
$3.66M Buy
+130,604
New +$3.73M 0.11% 85

Other funds holding DBMF

Aspiriant LLC's DBMF Position: Q2 2026 in Review

Aspiriant LLC reduced its iMGP DBi Managed Futures Strategy ETF (DBMF) stake by 2.3% in Q2 2026, selling an estimated $88.3K and leaving 123,644 shares worth $3.78M. The position accounts for 0.09% of the portfolio, ranked #84.

Aspiriant LLC first reported a position in DBMF in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.81M in Q1 2026. 328 funds tracked by Wall St. Rank hold DBMF as of Q2 2026.

  • Aspiriant LLC held 123,644 shares of iMGP DBi Managed Futures Strategy ETF worth $3.78M as of Q2 2026.
  • Aspiriant LLC sold 2,874 iMGP DBi Managed Futures Strategy ETF shares in Q2 2026, an estimated $88.3K.
  • iMGP DBi Managed Futures Strategy ETF made up 0.09% of Aspiriant LLC's portfolio in Q2 2026, its #84 holding.
  • Aspiriant LLC first reported a position in iMGP DBi Managed Futures Strategy ETF in Q4 2025 and has held it in 3 quarters since.
  • Aspiriant LLC's iMGP DBi Managed Futures Strategy ETF position peaked at $3.81M in Q1 2026.
  • 328 funds tracked by Wall St. Rank held iMGP DBi Managed Futures Strategy ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.